Dementia is associated with a sizeable public health burden that is growing rapidly as the population ages. In addition to cognitive impairments, individuals with dementia often come to clinical attention because of symptoms of a behavioral disturbance (e.g., irritability, agitation, aggression) or psychosis. The burden on caregivers is substantial and is increased when dementia is associated with behavioral and psychological symptoms, and particularly with agitation or aggression. Treatment of psychotic symptoms and agitation in individuals with dementia has often involved use of antipsychotic medications. In recent years, the risks associated with use of these agents in the older adult population have become apparent. There has been a growing need to develop guidelines for appropriate use of antipsychotic medications in dementia. The American Psychiatric Association Practice Guideline on the Use of Antipsychotics to Treat Agitation or Psychosis in Patients With Dementia seeks to fulfill this need to improve the care of patients with dementia who are exhibiting agitation or psychosis. The guideline focuses on the judicious use of antipsychotic medications when agitation or psychosis occurs in association with dementia. It is intended to apply to individuals with dementia in all settings of care as well as to care delivered by generalist and specialist clinicians. The guideline offers clear, concise, and actionable recommendation statements to help clinicians to incorporate recommendations into clinical practice, with the goal of improving quality of care. Each recommendation is given a rating that reflects the level of confidence that potential benefits of an intervention outweigh potential harms. Findings from an expert opinion survey have also been taken into consideration in making recommendations or suggestions. In addition to reviewing the available evidence on use of antipsychotics in treating agitation or psychosis in patients with dementia, the guideline provides guidance to clinicians on implementing these recommendations to enhance patient care.
Developed by experts on schizophrenia and exhaustively reviewed by APA members, the "American Psychiatric Association Practice Guideline for the Treatment of Patients With Schizophrenia" provides therapists with a set of patient care ...
This new edition of the practice guidelines on psychiatric evaluation for adults is the first set of the APA's guidelines developed under the new guideline development process.
The series also will identify those areas in which critical information is lacking and in which research could be expected to improve clinical decisions.
The American Psychiatric Association Practice Guideline for the Pharmacological Treatment of Patients With Alcohol Use Disorder seeks to reduce these substantial psychosocial and public health consequences of AUD for millions of affected ...
New York, Academic Press, 1984 Schechter M, Combrinck-Graham L: The normal development of the ... Washington, DC, American Psychiatric Press, 1988, pp 91–122 Shapiro T, Hertzig ME: Normal child and adolescent development, ...
... absolute neutrophil count and, in many countries, registration of the patient with a national registry; in fact, it appears that the risk of agranulocytosis is higher in older adults than in younger adults (Bishara and Taylor 2014).
An illustrative clinical case concludes each review, followed by brief information on other relevant studies. This book is a must-read for health care professionals and anyone who wants to learn more about the data behind clinical practice.
Frangou S, Lewis M, McCrone P. Efficacy of ethyl-eicosapentaenoic acid in bipolar depression: randomised double-blind placebo- controlled study. Br J Psychiatry. 2006;188:46- 170. 50. Sarris J, Mischoulon D, Schweitzer I. Omega-3 for ...
This practical guideline offers invaluable information to psychiatrists who care for patients with delirium. In helping the clinician provide treatments that address the underlying etiology of the delirium, it discusses...
This Clinical Handbook for the Management of Mood Disorders will equip clinicians with the knowledge to refine their diagnostic skills and implement treatment plans for mood disorders based on the most up-to-date evidence on interventions ...